UNSPSC 51434601: Etozolin

This classification denotes a loop diuretic and antihypertensive agent with the molecular formula C13H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UEO8UW9V1Z, chemically known as 3-methyl-4-oxo-5-piperidino-.delta.(sup2,a)-thiazolidineacetic acid ethyl ester but generally known as etozolin, which bears US NIH Compound Identifier 5384145. European Medicines Agency schedules Etozolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07344MIG.

UNSPSC 51434601 Etozolin is a Commodity code under which state and local governments procure emergency and critical-care medications for fire rescue, emergency medical services, and pharmacy benefit programs. Recent opportunities show solicitation of advanced life support medications including epinephrine, adenosine, labetalol, and diltiazem—injectable formulations used in acute cardiac and respiratory interventions—alongside broader generic pharmaceutical procurement through cooperative purchasing arrangements. State and local issuers range from municipal fire departments to state health and human services agencies, with cooperative purchasing alliances aggregating demand across multiple jurisdictions and member states. The scope extends from single-jurisdiction emergency medication supply contracts to statewide and multi-state pharmaceutical distribution agreements, reflecting both tactical procurement for specific operational needs and strategic contracting for inventory management and cost containment across public health and emergency-response systems.

Recent activity appears concentrated in Florida and Texas, with multi-state involvement through Minnesota-led cooperative purchasing. The City of Tampa's Purchasing Department issued Invitation for Bid 26P00188 for Advanced Life Support Medications due April 8, 2026, with an estimated contract value of $40,000.00 and a one-year term plus renewal options; the solicitation required medications with nine-month minimum shelf life, ten-day delivery windows, and included a 5 percent bid discount for Small Local Business Enterprise participation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with contract effectiveness July 1, 2026, and two-year terms. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013) in early April 2026 to explore direct-to-manufacturer pharmacy contracting models outside traditional pharmacy benefit manager and group purchasing organization channels, signaling early-stage procurement planning rather than immediate opportunity.